Human conglutinin
AssigneeNovo Industri A/S
InventorJens C. Jensenius
Life of this patent
Estimating the term…
Abstract
Human conglutinin, polyclonal, and monoclonal antibodies raised against human conglutinin, and their uses in therapy and diagnosis are described. Human conglutinin was obtained from human plasma by affinity chromatography with anti-bovine conglutinin antibody, has a relative molecular weight of 330 and 40 K unreduced and 66 K reduced as measured by SDS-PAGE, shows calcium-dependent and sugar inhibitable binding to complement-reacted immune complexes and zymosan, and immunological cross-reaction with anti-bovine conglutinin antibody.
Claims1
Human conglutinin in substantially pure form comprising a plasma protein of monomeric molecular weight of 40,000 daltons in the unreduced state and 66,000 daltons in the reduced state, and a polymeric relative molecular weight of 330,000 daltons in the unreduced state, said protein comprising in the monomeric reduced state the following amino acid composition:
- ______________________________________ Amino Acid Molar % ______________________________________ Asp 1.2 Glu 1.8 Ser 6.0 Gly 13.0 His 1.6 Arg 6.9 Thr 5.1 Ala 3.5 Pro 5.7 Tyr 3.2 Val 6.5 Met 1.5 Cys 10.1 Ile 6.5 Leu 18.0 Phe 4.5 Lys 4.8;
- ______________________________________
- said protein exhibiting calcium-dependent and sugar-inhiitable binding to complement-reacted immune complexes and zymosan, said protein being sensitive to collagenase digestion, and said protein cross-reacting with chicken and rabbit anti-bovine conglutinin antibody.
Dependencies are inferred from the claim text.